Proteomic analyses of the vitreous humour

Mediators of Inflammation

Volumn 2012, Issue , 2012, Pages

  Angi, Martina ^a   Kalirai, Helen ^a   Coupland, Sarah E ^a   Damato, Bertil E ^a   Semeraro, Francesco ^b   Romano, Mario R ^c  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b UNIVERSITY OF BRESCIA   (Italy)

^c HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN FIBER; PROTEOME;

DATA ANALYSIS; ELECTROSPRAY; ENUCLEATION; EYE INFLAMMATION; FLUORESCENCE ANALYSIS; HUMAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN DETERMINATION; PROTEOMICS; REVIEW; TANDEM MASS SPECTROMETRY; VISCOSITY; VITRECTOMY; VITREOUS BIOPSY; VITREOUS BODY; ANIMAL; ARTICLE; DIABETIC RETINOPATHY; METABOLISM; METHODOLOGY; VITREORETINOPATHY;

ANIMALIA;

ANIMALS; DIABETIC RETINOPATHY; HUMANS; PROTEOMICS; VITREORETINOPATHY, PROLIFERATIVE; VITREOUS BODY;

EID: 84866170795     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2012/148039     Document Type: Review

References (54)

1. Bishop P. N., Structural macromolecules and supramolecular organisation of the vitreous gel. Progress in Retinal and Eye Research 2000 19 3 323 344 2-s2.0-0034003134 10.1016/S1350-9462(99)00016-6 (Pubitemid 30122726)
2. Sebag J., Hart W., The vitreous. Adlers Physiology of the Eye 1992 Mosby St. Louis 268 347
3. Ulrich J. N., Spannagl M., Kampik A., Gandorfer A., Components of the fibrinolytic system in the vitreous body in patients with vitreoretinal disorders. Clinical and Experimental Ophthalmology 2008 36 5 431 436 2-s2.0-50849132525 10.1111/j.1442-9071.2008.01793.x
4. Bishop P. N., Takanosu M., Le Goff M., Mayne R., The role of the posterior ciliary body in the biosynthesis of vitreous humour. Eye 2002 16 4 454 460 2-s2.0-0036330632 10.1038/sj.eye.6700199 (Pubitemid 34845974)
5. Wu C. W., Sauter J. L., Johnson P. K., Chen C. D., Olsen T. W., Identification and localization of major soluble vitreous proteins in human ocular tissue. American Journal of Ophthalmology 2004 137 4 655 661 2-s2.0-1842504331 10.1016/j.ajo.2003.11.009 (Pubitemid 38446679)
6. Shitama T., Hayashi H., Noge S., Uchio E., Oshima K., Haniu H., Takemori N., Komori N., Matsumoto H., Proteome profiling of vitreoretinal diseases by cluster analysis. ProteomicsClinical Applications 2008 2 9 1265 1280 2-s2.0-53549115616 10.1002/prca.200800017
7. Cassidy L., Barry P., Shaw C., Duffy J., Kennedy S., Platelet derived growth factor and fibroblast growth factor basic levels in the vitreous of patients with vitreoretinal disorders. British Journal of Ophthalmology 1998 82 2 181 185 2-s2.0-0031976174 (Pubitemid 28176995)
8. Abu El-Asrar A. M., Nawaz M. I., Kangave D., Angiogenesis regulatory factors in the vitreous from patients with proliferative diabetic retinopathy. Acta Diabetologica. In press
9. Nagata K., Maruyama K., Uno K., Simultaneous analysis of multiple cytokines in the vitreous of patients with sarcoid uveitis. Investigative Ophthalmology & Visual Science 2012 53 7 3827 3833
10. Yoshimura T., Sonoda K. H., Sugahara M., Mochizuki Y., Enaida H., Oshima Y., Ueno A., Hata Y., Yoshida H., Ishibashi T., Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases. PLoS ONE 2009 4 12 2-s2.0-77949537099 10.1371/journal.pone.0008158 e8158
11. Mallick P., Kuster B., Proteomics: a pragmatic perspective. Nature Biotechnology 2010 28 7 695 709 2-s2.0-77954464041 10.1038/nbt.1658
12. Gao B. B., Clermont A., Rook S., Fonda S. J., Srinivasan V. J., Wojtkowski M., Fujimoto J. G., Avery R. L., Arrigg P. G., Bursell S. E., Aiello L. P., Feener E. P., Extracellular carbonic anhydrase mediates hemorrhagic retinal and cerebral vascular permeability through prekallikrein activation. Nature Medicine 2007 13 2 181 188 2-s2.0-33846991924 10.1038/nm1534
13. Gao B. B., Chen X., Timothy N., Aiello L. P., Feener E. P., Characterization of the vitreous proteome in diabetes without diabetic retinopathy and diabetes with proliferative diabetic retinopathy. Journal of Proteome Research 2008 7 6 2516 2525 2-s2.0-49849090387 10.1021/pr800112g
14. García-Ramírez M., Canals F., Hernández C., Colomé N., Ferrer C., Carrasco E., García-Arumí J., Simó R., Proteomic analysis of human vitreous fluid by fluorescence-based difference gel electrophoresis (DIGE): a new strategy for identifying potential candidates in the pathogenesis of proliferative diabetic retinopathy. Diabetologia 2007 50 6 1294 1303 2-s2.0-34247877623 10.1007/s00125-007-0627-y (Pubitemid 46701542)
15. Kim T., Kim S. J., Kim K., Profiling of vitreous proteomes from proliferative diabetic retinopathy and nondiabetic patients. Proteomics 2007 7 22 4203 4215 2-s2.0-36549073658 10.1002/pmic.200700745 (Pubitemid 350190291)
16. Koyama R., Nakanishi T., Ikeda T., Shimizu A., Catalogue of soluble proteins in human vitreous humor by one-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis and electrospray ionization mass spectrometry including seven angiogenesis-regulating factors. Journal of Chromatography B 2003 792 1 5 21 2-s2.0-0038798778 10.1016/S1570-0232(03)00133-8 (Pubitemid 36773797)
17. Neal R. E., Bettelheim F. A., Lin C., Winn K. C., Garland D. L., Zigler J. S., Alterations in human vitreous humour following cataract extraction. Experimental Eye Research 2005 80 3 337 347 2-s2.0-13844297450 10.1016/j.exer.2004.09.015 (Pubitemid 40249890)
18. Ouchi M., West K., Crabb J. W., Kinoshita S., Kamei M., Proteomic analysis of vitreous from diabetic macular edema. Experimental Eye Research 2005 81 2 176 182 2-s2.0-23144445854 10.1016/j.exer.2005.01.020 (Pubitemid 41080099)
19. Simó R., Higuera M., García-Ramírez M., Canals F., García-Arumí J., Hernández C., Elevation of apolipoprotein A-I and apolipoprotein H levels in the vitreous fluid and overexpression in the retina of diabetic patients. Archives of Ophthalmology 2008 126 8 1076 1081 2-s2.0-49449108549 10.1001/archopht.126.8.1076
20. Wang H., Feng L., Hu J. W., Characterisation of the vitreous proteome in proliferative diabetic retinopathy. Proteome Science 2012 10 1, article 15
21. Yamane K., Minamoto A., Yamashita H., Takamura H., Miyamoto-Myoken Y., Yoshizato K., Nabetani T., Tsugita A., Mishima H. K., Proteome analysis of human vitreous proteins. Molecular & Cellular Proteomics 2003 2 11 1177 1187 2-s2.0-2342608111
22. Yu J., Liu F., Cui S. J., Liu Y., Song Z. Y., Cao H., Chen F. E., Wang W. J., Sun T., Wang F., Vitreous proteomic analysis of proliferative vitreoretinopathy. Proteomics 2008 8 17 3667 3678 2-s2.0-52649171414 10.1002/pmic.200700824
23. Nakanishi T., Koyama R., Ikeda T., Shimizu A., Catalogue of soluble proteins in the human vitreous humor: comparison between diabetic retinopathy and macular hole. Journal of Chromatography B 2002 776 1 89 100 2-s2.0-0037173964 10.1016/S1570-0232(02)00078-8 (Pubitemid 34804346)
24. Kim S. J., Kim S., Park J., Differential expression of vitreous proteins in proliferative diabetic retinopathy. Current Eye Research 2006 31 3 231 240 2-s2.0-33644930329 10.1080/02713680600557030 (Pubitemid 43379193)
25. Domon B., Aebersold R., Options and considerations when selecting a quantitative proteomics strategy. Nature Biotechnology 2010 28 7 710 721 2-s2.0-77954523086 10.1038/nbt.1661
26. Skeie J. M., Mahajan V. B., Dissection of human vitreous body elements for proteomic analysis. Journal of Visualized Experiments 2011 47 2455 2-s2.0-79959197116 10.3791/2455
27. Johnson M. W., Improvements in the understanding and treatment of macular hole. Current Opinion in Ophthalmology 2002 13 3 152 160 2-s2.0-0036097785 10.1097/00055735-200206000-00004 (Pubitemid 34518199)
28. Mandal N., Heegaard S., Prause J. U., Honoré B., Vorum H., Ocular proteomics with emphasis on two-dimensional gel electrophoresis and mass spectrometry. Biological Procedures Online 2010 12 1 56 88 2-s2.0-78649831419 10.1007/s12575-009-9019-7
29. Patel N., Solanki E., Picciani R., Cavett V., Caldwell-Busby J. A., Bhattacharya S. K., Strategies to recover proteins from ocular tissues for proteomics. Proteomics 2008 8 5 1055 1070 2-s2.0-41149146541 10.1002/pmic.200700856 (Pubitemid 351441444)
30. Sebag J., Balazs E. A., Morphology and ultrastructure of human vitreous fibers. Investigative Ophthalmology and Visual Science 1989 30 8 1867 1871 2-s2.0-0024407627 (Pubitemid 19215012)
31. Garg U., Althahabi R., Amirahmadi V., Brod M., Blanchard C., Young T., Hyaluronidase as a liquefying agent for chemical analysis of vitreous fluid. Journal of Forensic Sciences 2004 49 2 388 391 2-s2.0-1542376939 (Pubitemid 38298471)
32. McNeil A. R., Gardner A., Stables S., Simple method for improving the precision of electrolyte measurements in vitreous humor. Clinical Chemistry 1999 45 1 135 136 2-s2.0-0032959491 (Pubitemid 29036399)
33. Liu T., Qian W. J., Mottaz H. M., Gritsenko M. A., Norbeck A. D., Moore R. J., Purvine S. O., Camp D. G., Smith R. D., Evaluation of multiprotein immunoaffnity subtraction for plasma proteomics and candidate biomaker discovery using mass spectrometry. Molecular and Cellular Proteomics 2006 5 11 2167 2174 2-s2.0-33750682085 10.1074/mcp.T600039-MCP200 (Pubitemid 44817028)
34. Gorg A., Obermaier C., Boguth G., The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 2000 21 6 1037 1053 (Pubitemid 30230771)
35. Rabilloud T., The whereabouts of 2D gels in quantitative proteomics. Methods in Molecular Biology 2012 893 25 35
36. Tannu N. S., Hemby S. E., Two-dimensional fluorescence difference gel electrophoresis for comparative proteomics profiling. Nature Protocols 2006 1 4 1732 1742 2-s2.0-34247627759 10.1038/nprot.2006.256 (Pubitemid 46778055)
37. Hernández C., García-Ramírez M., Colomé N., Villarroel M., Corraliza L., García-Pacual L., Casado J., Canals F., Simó R., New pathogenic candidates for diabetic macular edema detected by proteomic analysis. Diabetes Care 2010 33 7, article e92 2-s2.0-77958195989 10.2337/dc10-0232
38. Karas M., Hillenkamp F., Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons. Analytical Chemistry 1988 60 20 2299 2301 2-s2.0-0024289037
39. Fenn J. B., Mann M., Meng C. K., Wong S. F., Whitehouse C. M., Electrospray ionization for mass spectrometry of large biomolecules. Science 1989 246 4926 64 71 2-s2.0-0024438708 (Pubitemid 19252085)
40. Aebersold R., Mann M., Mass spectrometry-based proteomics. Nature 2003 422 6928 198 207 2-s2.0-0037435030 10.1038/nature01511 (Pubitemid 36362757)
41. Cottrell J. S., Protein identification by peptide mass fingerprinting. Peptide Research 1994 7 3 115 124 2-s2.0-0028429419 (Pubitemid 2109897)
42. Lam T. C., Chun R. K., Li K. K., To C. H., Application of proteomic technology in eye research: a mini review. Clinical and Experimental Optometry 2008 91 1 23 33 2-s2.0-36649036806 10.1111/j.1444-0938.2007.00194.x
43. Shen Y., Zhao R., Berger S. J., Anderson G. A., Rodriguez N., Smith R. D., High-efficiency nanoscale liquid chromatography coupled on-line with mass spectrometry using nanoelectrospray ionization for proteomics. Analytical Chemistry 2002 74 16 4235 4249 2-s2.0-0037102411 10.1021/ac0202280 (Pubitemid 34912927)
44. Peng J., Elias J. E., Thoreen C. C., Licklider L. J., Gygi S. P., Evaluation of multidimensional chromatography coupled with tandem mass spectrometry (LC/LC-MS/MS) for large-scale protein analysis: the yeast proteome. Journal of Proteome Research 2003 2 1 43 50 2-s2.0-0037277179 10.1021/pr025556v (Pubitemid 36207189)
45. Qian W. J., Jacobs J. M., Camp D. G., Monroe M. E., Moore R. J., Gritsenko M. A., Calvano S. E., Lowry S. F., Xiao W., Moldawer L. L., Davis R. W., Tompkins R. G., Smith R. D., Comparative proteome analyses of human plasma following in vivo lipopolysaccharide administration using multidimensional separations coupled with tandem mass spectrometry. Proteomics 2005 5 2 572 584 2-s2.0-20944449918 10.1002/pmic.200400942 (Pubitemid 40262074)
46. Nesvizhskii A. I., Vitek O., Aebersold R., Analysis and validation of proteomic data generated by tandem mass spectrometry. Nature Methods 2007 4 10 787 797 2-s2.0-35848929694 10.1038/nmeth1088 (Pubitemid 350055575)
47. Lee R. W., Dick A. D., Current concepts and future directions in the pathogenesis and treatment of non-infectious intraocular inflammation. Eye 2012 26 1 17 28
48. de Smet M. D., Taylor S. R., Bodaghi B., Understanding uveitis: the impact of research on visual outcomes. Progress in Retinal and Eye Research 2011 30 6 452 470
49. de Smet M. D., Chan C. C., Regulation of ocular inflammationwhat experimental and human studies have taught us. Progress in Retinal and Eye Research 2001 20 6 761 797 2-s2.0-0034809510 10.1016/S1350-9462(01)00011-8 (Pubitemid 32923071)
50. Bahk S. C., Lee S. H., Jang J. U., Choi C. U., Lee B. S., Chae S. C., Song H. J., Park Z. Y., Yang Y. S., Chung H. T., Identification of crystallin family proteins in vitreous body in rat endotoxin-induced uveitis: involvement of crystallin truncation in uveitis pathogenesis. Proteomics 2006 6 11 3436 3444 2-s2.0-33745087484 10.1002/pmic.200500779 (Pubitemid 43886159)
51. Deeg C. A., Amann B., Raith A. J., Kaspers B., Inter- and intramolecular epitope spreading in equine recurrent uveitis. Investigative Ophthalmology and Visual Science 2006 47 2 652 656 2-s2.0-33644849984 10.1167/iovs.05-0789 (Pubitemid 46768394)
52. Werry H., Gerhards H., The surgical therapy of equine recurrent uveitis. Tierarztliche Praxis 1992 20 2 178 186 2-s2.0-0026844120
53. Deeg C. A., Altmann F., Hauck S. M., Schoeffmann S., Amann B., Stangassinger M., Ueffing M., Down-regulation of pigment epithelium-derived factor in uveitic lesion associates with focal vascular endothelial growth factor expression and breakdown of the blood-retinal barrier. Proteomics 2007 7 9 1540 1548 2-s2.0-34248652982 10.1002/pmic.200600795 (Pubitemid 46775884)
54. Hauck S. M., Hofmaier F., Dietter J., Label-free LC-MSMS analysis of vitreous from autoimmune uveitis reveals a significant decrease in secreted Wnt signalling inhibitors DKK3 and SFRP2. Journal of Proteomics 2012 75 14 4545 4554